Temperature Management Systems Market

The size of global temperature management systems market in terms of revenue was estimated to be worth $3.0 billion in 2023 and is poised to reach $3.9 billion by 2028, growing at a CAGR of 4.9% from 2023 to 2028. The research study consists of an industry trend analysis, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

Increasing prevalence of chronic and infectious diseases, rising number of surgical procedures, increasing number of hypothermia cases, increasing growth opportunities in emerging markets, growing number of product launches, contracts and agreements between market players and developing healthcare infrastructure.

Attractive Opportunities in the Temperature Management Systems Market

To know about the assumptions considered for the study, Request for Free Sample Report

Global temperature management systems dynamics

DRIVER: Increasing number of hypothermia cases

Hypothermia is caused due to environmental exposure, drug intoxication, or metabolic or nervous system dysfunction. Hypothermia occurs when the body’s temperature falls below 35°C. Annually, thousands die of primary hypothermia, and an unknown number die of secondary hypothermia worldwide. Hypothermia can be expected in emergency patients in the prehospital phase. Injured and intoxicated patients cool quickly, even in subtropical regions. Therefore, preventive measures are important to avoid hypothermia or cooling in ill or injured patients.

Hypothermia is associated with marked depression of cerebral blood flow and oxygen requirement, reduced cardiac output, and decreased arterial pressure. Victims can appear to be clinically dead because of marked depression of brain and cardiovascular function; however, full resuscitation with intact neurological recovery is possible. Alcohol or drug intoxication is the dominant precipitating factor. Around 20,000 hypothermia-related deaths occur every year in Britain. In the US and Canada, the number of hypothermia-related deaths is estimated at 25,000 and 8,000, respectively. Preventing inadvertent perioperative hypothermia helps to reduce surgical-site infections, the length of hospital stays, and the cost per patient. The need to reduce the occurrence of hypothermia will drive the demand for temperature management systems.

RESTRAINT: Lack of awareness regarding temperature management systems in developing countries

The proper use of warming and cooling systems to manage the core temperature of patients requires professionals with relevant experience and knowledge of the methodology. The launch of new and technologically advanced monitoring devices by market players has further created a need for proper training for their effective usage. Such advancements help in providing results of near-core and core temperature ranges to avoid additional risks of high fever and hypothermia in pre-and post-operative setups. However, the lack of awareness among doctors and healthcare practitioners about advancements that are incorporated by manufacturers, coupled with a dearth of skilled personnel who can effectively operate and process these devices, are the major factors limiting their adoption.

Despite advances in scientific research, several international surveys show low compliance in temperature management, with implementation rates between 13% and 34%. Therefore, barriers to implementation were identified as a lack of legislation, information, funding, equipment, and competence. These barriers may be more pronounced in low-resource settings and developing countries, which is restricting the growth of the temperature management systems market.

OPPORTUNITY: Growing number of contracts and agreements between market players

Over the years, the number of companies offering temperature management systems has increased globally. Major market players are focusing on strengthening their product offerings, distribution networks, and geographic presence by entering into contracts and agreements with other established and emerging players in the market. This provides growth opportunities for emerging companies in the market. For instance,

• In July 2023, ZOLL Medical Corporation (US) (a subsidiary of Asahi Kasei) entered into an agreement with BrainCool, a medical device company specializing in temperature management solutions. This agreement was aimed at the exclusive distribution of the BrainCool System/IQool System and the IQool System Pads in the US and key markets in Europe. The companies are working toward expanding distribution to select markets in Asia.
• In July 2022, Gentherm acquired Jiangmen Dacheng Medical Equipment Co., Ltd, a manufacturer of medical materials and medical equipment, including patient temperature management solutions.
• In May 2022, the Surgical Company Group (TSC Group) announced the completion of the acquisition by Duomed Group of the distribution activities of TSC Group in France and the Benelux, notably the Adhesia, Sebac, and Hospithera brands.
• In January 2022, ICU Medical announced that it had completed its acquisition of Smiths Medical from Smiths Group plc. The Smiths Medical business includes syringe and ambulatory infusion devices, vascular access, and vital care products. When combined with ICU Medical’s existing businesses, the combined companies create a leading infusion therapy company with estimated pro forma combined revenues of approximately USD 2.5 billion.
• In June 2021, ZOLL Medical Corporation (US) (a subsidiary of Asahi Kasei) and Wallaby Medical Technologies signed a distribution agreement whereby Wallaby will manage the sales and distribution of ZOLL’s temperature management products in China.
• In June 2021, ZOLL Medical Corporation (US) (a subsidiary of Asahi Kasei) and Global Healthcare SG signed an exclusive agreement to distribute portable targeted temperature management systems in the Asia Pacific.
• In March 2021, The Surgical Company (Netherlands) announced an agreement with Next Level Development TSC-PTM to develop, produce, and globally distribute specialist medical equipment to prevent hypothermia and for the warming of patients undergoing surgery.

Such strategies help companies expand their customer base and extend their presence in untapped, emerging markets.

CHALLENGE: Product recalls

Product recalls are often associated with quality failures and may negatively affect customer satisfaction and firm performance. A product recall occurs when safety issues or defects in a product are found that might endanger consumers or put the producer or seller at risk of legal action.

Mentioned below are some key examples in this regard:

• Smiths Medical recalled NORMOFLO Irrigation Fluid Warmers and Warming Sets due to the possibility of harmful levels of aluminum leaching into the fluid path of the warmers. When the fluid circulates through the patient’s body, the patient can be exposed to high levels of aluminum. Exposure to toxic levels of aluminum may not be easily recognized, and exposure effects may cause serious adverse events, including death.
• 3M Company recalled more than 165,000 Bair Hugger surgical warming blankets due to a design problem that could allow patients in surgery to experience dangerous body temperature changes. The US Food and Drug Administration received at least one report of a patient going into hypothermia during surgery involving the blankets. Air forced through the inflatable blankets helps maintain normal body temperature. An FDA alert said a design change in certain Bair Hugger blankets made airflow blockage more likely. This could prevent the blankets from fully inflating.
• Vyaire Medical announced an immediate global recall of the enFlow disposable cartridges used with the enFlow fluid warming system (part numbers 980200EU and 980202EU). Vyaire is directing customers to suspend the use of the enFlow system and follow instructions provided by the company in its recall notice with regard to the affected cartridges.

In such a case, the product is taken off the market, resulting in financial loss for the producing company and potential damage to the company’s reputation. It clashes sales, testing customer relationships, and disrupting supply chains.

Temperature Management Systems Ecosystem

Prominent companies in this market include well-established manufacturers of temperature management systems Market and offer a wide range of products. These companies have been operating in the market for several years and possess a diversified product portfolio, state-of-the-art technologies, and strong global sales and marketing networks. Prominent companies in this market include 3M Company (US), GE Healthcare (US), Dragerwerk AG & Co. KGAA (Germany), Asahi-kasei Corporation (Japan) and Becton, Dickinson and Company (US).

In 2022, Patient Warming Systems segment to observe highest growth rate of the temperature management systems industry, by product.

Based on the Product, The Temperature Management Systems market, by product, has been segmented into patient warming systems, patient cooling systems, and accessories for patient warming/cooling systems. Patient warming systems will drive the growth of the market due to growing number of product launches contracts and agreements between market players. For Instance In June 2023, Dragerwerk AG & Co. KGAA has launched the new patient warming systems Babyroo TN300 that offers supportive lung protection and temperature stability to a newborn. Also, In July 2023, Asahi-kasei Corporation signed an agreement with BrainCool for the exclusive distribution of the BrainCool System/IQool System and the IQool System Pads in the US and Europe market.

In 2022, Perioperative care segment to dominate the temperature management systems industry, by the application.

Based on application, the the temperature management systems market is segmented Perioperative care, acute care, newborn care, and other applications. Perioperative care is expected to grow highest due to the increasing number of hypothermia cases. In an operating room, managing intraoperative hypothermia is very important for eliminating surgical bleeding, surgical-site infections, and wound infections, all of which can ultimately lead to a higher mortality rate.

To know about the assumptions considered for the study, download the pdf brochure

The global temperature management systems market is segmented into North America, Europe, Asia Pacific, and Rest of the World. North America market is expected to rise due to increasing geriatric population and the rising incidence of chronic diseases, alongside an increasing number of surgical procedures and surgical centers, are supporting the growth of the market.

The temperature management systems is dominated by players such  3M Company (US), GE Healthcare (US), Dragerwerk AG & Co. KGAA (Germany), Asahi-kasei Corporation (Japan), Becton, Dickinson and Company (US).

Scope of the Temperature Management Systems Industry:

This research report categorizes the temperature management systems market to forecast revenue and analyze trends in each of the following submarkets:

Recent Developments of Temperature Management Systems Industry

• In June 2023, Dragerwerk AG & Co. KGAA has launched the FDA-cleared Babyroo TN300, a new open warmer that offers supportive lung protection and temperature stability from the moment of birth through discharge.
• In July 2023, Asahi-kasei Corporation (Japan) signed an agreement with BrainCool, a medical device company specializing in temperature management solutions, for the exclusive distribution of the BrainCool System/IQool System and the IQool System Pads in the US and key markets in Europe. The companies are working toward expanding distribution to select markets in Asia.
• In January 2022, ICU Medical completed the acquisition of Smiths Medical from Smiths Group plc. The Smiths Medical business includes syringe and ambulatory infusion devices, vascular access, and vital care products. When combined with ICU Medical’s existing businesses, the combined companies create a leading infusion therapy company with estimated pro forma combined revenues of approximately USD 2.5 billion.
• In July 2022, Gentherm acquired Jiangmen Dacheng Medical Equipment Co., Ltd., a manufacturer of medical materials and medical equipment, including patient temperature management solutions.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst